Medical News

RSS

Acorda Therapeutics announces Phase 3 Fampridine-SR trial findings

Data from a long-term open-label extension study from the first Phase 3 Fampridine-SR trial, known as MS-F203, showed that 24.9% of extension study participants with multiple sclerosis (MS) met the criteria as Extension Timed Walk Responders (ETWRs) after one year of treatment and demonstrated improved walking speed over a two year period.

10 Sep 2009

Survey reveals that hand-washing behaviors are poor despite H1N1 swine flu

With the White House estimating that 30 to 50 percent of Americans will contract H1N1 flu this season, you’d think more people would be focused on prevention.

10 Sep 2009

North Carolina Biotechnology Center establishes Research Triangle Park headquarters

To continue the state life science industry’s record-setting growth rate, the North Carolina Biotechnology Center, with the help of statewide partners, is building an addition to its Research Triangle Park headquarters.

10 Sep 2009

Phase Forward's Empirica Suite to be showcased at the 3rd annual conference

Phase Forward, a leading provider of data management solutions for clinical trials and drug safety, will participate in the 3rd annual World Drug Safety Congress Europe, to be held September 15-18 at the Bloomsbury Hotel in London, U.K.

10 Sep 2009

High cost of health care not justified

A policy paper that identifies and analyzes the key drivers of health care costs was released today by the American College of Physicians (ACP). Controlling Health Care Costs While Promoting the Best Possible Health Outcomes provides nearly four dozen recommendations to achieve better quality care to more people.

10 Sep 2009

Cord Blood America to complete its new Las Vegas laboratory on schedule

Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com ) focused on bringing the life saving potential of stem cells, a biological insurance policy for families nationwide and internationally, said today that it is on schedule to complete the construction of its new Las Vegas laboratory by the first week of October.

10 Sep 2009

EPO issues grant for a patent in Kreutzer-Limmer III patent series

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the European Patent Office (EPO) has issued a notification of intent to grant for a patent in the Kreutzer-Limmer III patent series (EP Application No 02702247.4). This patent series stems from the pioneering RNAi research performed by scientists at Ribopharma AG, which was acquired by Alnylam in 2003.

10 Sep 2009

Event to mark Wisdom Hospice’s 25th anniversary celebration

A lecture to mark the 25th anniversary of the Wisdom Hospice in Rochester is taking place at the University of Kent's Medway campus on Monday, 5 October.

10 Sep 2009

Results of the survey after President Obama's speech to a Joint Session of Congress released

Immediately after President Obama's speech to a Joint Session of Congress last night, Clarus Research Group surveyed 44 of the nation's top political, legislative and communications strategists -- representing a broad array of expertise in politics, government, media consulting, lobbying, and public relations.

10 Sep 2009

METOZOLV drug approved for treating gastroesophageal reflux disease

Wilmington Pharmaceuticals announced today the U.S. Food and Drug Administration (FDA) has granted marketing approval for METOZOLV ODT (metoclopramide HCl), an orally disintegrating formulation of metoclopramide for the treatment of gastroesophageal reflux disease (GERD) and diabetic gastroparesis.

10 Sep 2009

QIAGEN's new QIAsafe DNA blood products launched

Biomatrica, Inc. and QIAGEN announce the launch of QIAGEN's new QIAsafe DNA Blood Products, the first dry blood storage available on a matrix based on Biomatrica's innovative SampleMatrix(R) technology.

From QIAGEN Manchester Limited 10 Sep 2009

Swine flu more lethal than seasonal flu

Pandemic swine flu can infect cells deeper in the lungs than seasonal flu can, according to a new study published today in Nature Biotechnology.

10 Sep 2009

Applications for the Pancreatic Cancer Action Network and AACR 2010 Research Grants Program invited

The Pancreatic Cancer Action Network, in partnership with the American Association for Cancer Research (AACR), is now accepting applications for the 2010 Research Grants Program. This year's grants program will be administered through the AACR's rigorous peer-review system to ensure the highest quality science is supported. The grant terms will begin on July 1, 2010.

10 Sep 2009

BELLUS Health to raise over C$9 million from rights offering

BELLUS Health Inc. ("BELLUS Health" or the "Company") (TSX: BLU) today disclosed the results of its previously announced rights offering. The Company will raise an aggregate of C$9,687,233 from the rights offering and issue a total of 52,363,419 common shares at a price of C$0.185 per share (the "Subscription Price").

10 Sep 2009

Medical liability reforms will hold down defensive medicine costs

President Obama, in his address to a joint session of Congress tonight, stated that “defensive medicine” does contribute to unnecessary costs in healthcare and will now explore options for medical liability reform. The American Association of Neurological Surgeons (AANS) and Congress of Neurological Surgeons (CNS) applaud the President’s inclusion of this key element as lawmakers move forward with an overall healthcare reform plan.

10 Sep 2009

Catalyst Health Solutions ranks 14th on the Fortune 100 Fastest-Growing Companies list

Catalyst Health Solutions, Inc. (NASDAQ:CHSI) announced today that it was named to the Fortune 100 Fastest-Growing Companies list, making its second consecutive appearance on the annual ranking and third within the past five years. Catalyst ranked Number 14 on the list of fast-growing health care companies and Number 93 overall among all industries.

10 Sep 2009

Business vertical-focused learning solutions for the health care industry launched by TIS

Global learning solutions provider-Tata Interactive Systems (TIS)-has recently announced the launch of its first business vertical-focused learning solutions for organizations in the health care industry. TIS formally launched this initiative with the appointment of Candida Chandorkar as Vice President - Global Healthcare Solutions, a move from her earlier position as Vice President - ANZ.

10 Sep 2009

Season's Practice launches women health and wellness solutions in Northeast Ohio

Season's Practice has opened its doors to women in Northeast Ohio who are seeking alternative health and wellness solutions to improve their overall health and well-being.

10 Sep 2009

Second-quarter fiscal 2009 results announced by Streamline Health Solutions

Streamline Health Solutions, Inc. (Nasdaq: STRM) today announced financial results for the second quarter and six months, ended July 31, 2009.

10 Sep 2009

Hyland Software offers grant assistance to fund OnBase investments

At a time when revenues aren't growing, many organizations are looking for ways to drive out costs and inefficiencies. Because it's proven to do exactly these things by better managing processes and the documents that go along with them, many are turning to enterprise content management (ECM) applications (http://onbase.com/English/Products). But here's the roadblock: budgets are tighter than ever, so how do these projects get funded?

10 Sep 2009